Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been suggested that children with constitutional growth delay might have a transient
immaturity
of the neurotransmitter pathways necessary for the control of
growth hormone releasing hormone
(
GHRH
) secretion. In this study we evaluated the effects of two consecutive
GHRH
boluses (1 microgram/kg, i.v.) in nine prepubertal boys with constitutional growth delay. Growth hormone (GH) responses to
GHRH
administration were similar to that observed in normal children (first
GHRH
bolus, GH net incremental area under the curve (nAUC) +/- SE: 788 +/- 244 vs 984 +/- 242 ng/ml per hour; second bolus, GHnAUC: 657 +/- 122 vs 541 +/- 129 ng/ml per hour, respectively). These data suggest that no relevant abnormalities in the mechanisms determining the somatotroph sensitivity to
GHRH
are present in children with constitutional growth delay.
...
PMID:Effect of two consecutive administrations of GHRH in children with constitutional growth delay. 197 18